Insulin-like growth factor inhibits vascular contraction to 5- hydroxytryptamine: Involvement of tyrosine phosphatase

Alessandra Melis, Stephanie W. Watts, Jennifer Florian, Susan Klarr, R. Clinton Webb

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


This study tests the hypothesis that insulin-like growth factor 1 (IGF- 1)-induced vasodilation is due to the stimulation of tyrosine phosphatase. Rat aortic segments (endothelium intact) were placed in muscle baths for force measurement. Segments were contracted to serotonin [5-hydroxytyptamine (5-HT), 10-7-10-5 M] before and after incubation with IGF-1 (10-100 nM; 90 min). IGF-1 caused a 20% inhibition of 5-HT-induced contractions. This inhibition was reversed by the tyrosine phosphatase inhibitors sodium orthovanadate and molybdate. Orthovanadate did not alter inhibitory properties of the calcium channel antagonist verapamil, suggesting that the phosphatase inhibitors were relatively specific. IGF-1-induced inhibition was not altered by blockade of nitric oxide synthase. Western blot analysis confirmed that the 5-HT-induced stimulation of tyrosine phosphorylation of the 42-kDa extracellular signal-regulated mitogen-activated protein kinase protein was reduced by IGF-1 (52% inhibition), an inhibition that was attenuated by orthovanadate. These data are consistent with the hypothesis that the vasodilator activity of IGF-1 is mediated by the activation of a tyrosine phosphatase. (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)137-145
Number of pages9
JournalGeneral Pharmacology
Issue number2
StatePublished - Feb 2000
Externally publishedYes


  • Insulin-like growth factor
  • Orthovanadate
  • Rat aorta
  • Tyrosine phosphatase

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Insulin-like growth factor inhibits vascular contraction to 5- hydroxytryptamine: Involvement of tyrosine phosphatase'. Together they form a unique fingerprint.

Cite this